Diagnostic and Management Approach for Small Fiber Neuropathy

Diagnostic Evaluation

Skin biopsy with intraepidermal nerve fiber density assessment is the gold standard for diagnosing small fiber neuropathy, particularly when conventional nerve conduction studies are normal 1, 2
IENFD assessment using PGP 9.5 immunohistochemistry is a validated, reproducible marker of small fiber sensory pathology with sensitivity of 77.2-88% and specificity of 79.6-88.8% 3, 4
Quantitative sensory testing (QST) for thermal thresholds can complement skin biopsy in diagnosing SFN 3, 4
Autonomic function tests like quantitative sudomotor axon reflex test (QSART) and thermoregulatory sweat testing can document small fiber dysfunction with high sensitivity 2

Avoid triggers that exacerbate symptoms while maintaining normal activities as much as possible 5
Caution patients against excessive cooling of extremities which may worsen tissue damage 5

Small fiber damage often precedes large fiber damage in diabetic neuropathy 3, 4
IENF density is significantly reduced in diabetic patients even with normal nerve conduction, suggesting early small fiber damage 4, 6
Strict glycemic control is essential for preventing progression 3, 4

Relying solely on nerve conduction studies will miss SFN, as these tests only assess large fiber function 3, 1
Excessive cooling as a pain relief strategy may worsen tissue damage and lead to ulcerations 5
Consider repeat skin biopsy in select cases to monitor disease progression or treatment response 4